Transdermal Skin Patches-EMEA Market Status and Trend Report 2013-2023
Report Summary
Transdermal Skin Patches-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Transdermal Skin Patches industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Transdermal Skin Patches 2013-2017, and development forecast 2018-2023
Main market players of Transdermal Skin Patches in EMEA, with company and product introduction, position in the Transdermal Skin Patches market
Market status and development trend of Transdermal Skin Patches by types and applications
Cost and profit status of Transdermal Skin Patches, and marketing status
Market growth drivers and challenges
The report segments the EMEA Transdermal Skin Patches market as:
EMEA Transdermal Skin Patches Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Transdermal Skin Patches Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Drug in Adhesive
Matrix
Reservoir
Vapor
Other
EMEA Transdermal Skin Patches Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
EMEA Transdermal Skin Patches Market: Players Segment Analysis (Company and Product introduction, Transdermal Skin Patches Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Transdermal Skin Patches-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Transdermal Skin Patches industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Transdermal Skin Patches 2013-2017, and development forecast 2018-2023
Main market players of Transdermal Skin Patches in EMEA, with company and product introduction, position in the Transdermal Skin Patches market
Market status and development trend of Transdermal Skin Patches by types and applications
Cost and profit status of Transdermal Skin Patches, and marketing status
Market growth drivers and challenges
The report segments the EMEA Transdermal Skin Patches market as:
EMEA Transdermal Skin Patches Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Transdermal Skin Patches Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Drug in Adhesive
Matrix
Reservoir
Vapor
Other
EMEA Transdermal Skin Patches Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
EMEA Transdermal Skin Patches Market: Players Segment Analysis (Company and Product introduction, Transdermal Skin Patches Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF TRANSDERMAL SKIN PATCHES
1.1 Definition of Transdermal Skin Patches in This Report
1.2 Commercial Types of Transdermal Skin Patches
1.2.1 Drug in Adhesive
1.2.2 Matrix
1.2.3 Reservoir
1.2.4 Vapor
1.2.5 Other
1.3 Downstream Application of Transdermal Skin Patches
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Transdermal Skin Patches
1.5 Market Status and Trend of Transdermal Skin Patches 2013-2023
1.5.1 EMEA Transdermal Skin Patches Market Status and Trend 2013-2023
1.5.2 Regional Transdermal Skin Patches Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Transdermal Skin Patches in EMEA 2013-2017
2.2 Consumption Market of Transdermal Skin Patches in EMEA by Regions
2.2.1 Consumption Volume of Transdermal Skin Patches in EMEA by Regions
2.2.2 Revenue of Transdermal Skin Patches in EMEA by Regions
2.3 Market Analysis of Transdermal Skin Patches in EMEA by Regions
2.3.1 Market Analysis of Transdermal Skin Patches in Europe 2013-2017
2.3.2 Market Analysis of Transdermal Skin Patches in Middle East 2013-2017
2.3.3 Market Analysis of Transdermal Skin Patches in Africa 2013-2017
2.4 Market Development Forecast of Transdermal Skin Patches in EMEA 2018-2023
2.4.1 Market Development Forecast of Transdermal Skin Patches in EMEA 2018-2023
2.4.2 Market Development Forecast of Transdermal Skin Patches by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Transdermal Skin Patches in EMEA by Types
3.1.2 Revenue of Transdermal Skin Patches in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Transdermal Skin Patches in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Transdermal Skin Patches in EMEA by Downstream Industry
4.2 Demand Volume of Transdermal Skin Patches by Downstream Industry in Major Countries
4.2.1 Demand Volume of Transdermal Skin Patches by Downstream Industry in Europe
4.2.2 Demand Volume of Transdermal Skin Patches by Downstream Industry in Middle East
4.2.3 Demand Volume of Transdermal Skin Patches by Downstream Industry in Africa
4.3 Market Forecast of Transdermal Skin Patches in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL SKIN PATCHES
5.1 EMEA Economy Situation and Trend Overview
5.2 Transdermal Skin Patches Downstream Industry Situation and Trend Overview
CHAPTER 6 TRANSDERMAL SKIN PATCHES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Transdermal Skin Patches in EMEA by Major Players
6.2 Revenue of Transdermal Skin Patches in EMEA by Major Players
6.3 Basic Information of Transdermal Skin Patches by Major Players
6.3.1 Headquarters Location and Established Time of Transdermal Skin Patches Major Players
6.3.2 Employees and Revenue Level of Transdermal Skin Patches Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 TRANSDERMAL SKIN PATCHES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson
7.1.1 Company profile
7.1.2 Representative Transdermal Skin Patches Product
7.1.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 Novartis AG
7.2.1 Company profile
7.2.2 Representative Transdermal Skin Patches Product
7.2.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Novartis AG
7.3 Mylan N.V.
7.3.1 Company profile
7.3.2 Representative Transdermal Skin Patches Product
7.3.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Mylan N.V.
7.4 Teva Pharmaceutical Industries
7.4.1 Company profile
7.4.2 Representative Transdermal Skin Patches Product
7.4.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.5 Luye Pharma Group
7.5.1 Company profile
7.5.2 Representative Transdermal Skin Patches Product
7.5.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Luye Pharma Group
7.6 Hisamitsu Pharmaceutical
7.6.1 Company profile
7.6.2 Representative Transdermal Skin Patches Product
7.6.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
7.7 Mundipharma International
7.7.1 Company profile
7.7.2 Representative Transdermal Skin Patches Product
7.7.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Mundipharma International
7.8 Purdue Pharma
7.8.1 Company profile
7.8.2 Representative Transdermal Skin Patches Product
7.8.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Purdue Pharma
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL SKIN PATCHES
8.1 Industry Chain of Transdermal Skin Patches
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL SKIN PATCHES
9.1 Cost Structure Analysis of Transdermal Skin Patches
9.2 Raw Materials Cost Analysis of Transdermal Skin Patches
9.3 Labor Cost Analysis of Transdermal Skin Patches
9.4 Manufacturing Expenses Analysis of Transdermal Skin Patches
CHAPTER 10 MARKETING STATUS ANALYSIS OF TRANSDERMAL SKIN PATCHES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Transdermal Skin Patches in This Report
1.2 Commercial Types of Transdermal Skin Patches
1.2.1 Drug in Adhesive
1.2.2 Matrix
1.2.3 Reservoir
1.2.4 Vapor
1.2.5 Other
1.3 Downstream Application of Transdermal Skin Patches
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Transdermal Skin Patches
1.5 Market Status and Trend of Transdermal Skin Patches 2013-2023
1.5.1 EMEA Transdermal Skin Patches Market Status and Trend 2013-2023
1.5.2 Regional Transdermal Skin Patches Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Transdermal Skin Patches in EMEA 2013-2017
2.2 Consumption Market of Transdermal Skin Patches in EMEA by Regions
2.2.1 Consumption Volume of Transdermal Skin Patches in EMEA by Regions
2.2.2 Revenue of Transdermal Skin Patches in EMEA by Regions
2.3 Market Analysis of Transdermal Skin Patches in EMEA by Regions
2.3.1 Market Analysis of Transdermal Skin Patches in Europe 2013-2017
2.3.2 Market Analysis of Transdermal Skin Patches in Middle East 2013-2017
2.3.3 Market Analysis of Transdermal Skin Patches in Africa 2013-2017
2.4 Market Development Forecast of Transdermal Skin Patches in EMEA 2018-2023
2.4.1 Market Development Forecast of Transdermal Skin Patches in EMEA 2018-2023
2.4.2 Market Development Forecast of Transdermal Skin Patches by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Transdermal Skin Patches in EMEA by Types
3.1.2 Revenue of Transdermal Skin Patches in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Transdermal Skin Patches in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Transdermal Skin Patches in EMEA by Downstream Industry
4.2 Demand Volume of Transdermal Skin Patches by Downstream Industry in Major Countries
4.2.1 Demand Volume of Transdermal Skin Patches by Downstream Industry in Europe
4.2.2 Demand Volume of Transdermal Skin Patches by Downstream Industry in Middle East
4.2.3 Demand Volume of Transdermal Skin Patches by Downstream Industry in Africa
4.3 Market Forecast of Transdermal Skin Patches in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL SKIN PATCHES
5.1 EMEA Economy Situation and Trend Overview
5.2 Transdermal Skin Patches Downstream Industry Situation and Trend Overview
CHAPTER 6 TRANSDERMAL SKIN PATCHES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Transdermal Skin Patches in EMEA by Major Players
6.2 Revenue of Transdermal Skin Patches in EMEA by Major Players
6.3 Basic Information of Transdermal Skin Patches by Major Players
6.3.1 Headquarters Location and Established Time of Transdermal Skin Patches Major Players
6.3.2 Employees and Revenue Level of Transdermal Skin Patches Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 TRANSDERMAL SKIN PATCHES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson
7.1.1 Company profile
7.1.2 Representative Transdermal Skin Patches Product
7.1.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 Novartis AG
7.2.1 Company profile
7.2.2 Representative Transdermal Skin Patches Product
7.2.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Novartis AG
7.3 Mylan N.V.
7.3.1 Company profile
7.3.2 Representative Transdermal Skin Patches Product
7.3.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Mylan N.V.
7.4 Teva Pharmaceutical Industries
7.4.1 Company profile
7.4.2 Representative Transdermal Skin Patches Product
7.4.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.5 Luye Pharma Group
7.5.1 Company profile
7.5.2 Representative Transdermal Skin Patches Product
7.5.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Luye Pharma Group
7.6 Hisamitsu Pharmaceutical
7.6.1 Company profile
7.6.2 Representative Transdermal Skin Patches Product
7.6.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
7.7 Mundipharma International
7.7.1 Company profile
7.7.2 Representative Transdermal Skin Patches Product
7.7.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Mundipharma International
7.8 Purdue Pharma
7.8.1 Company profile
7.8.2 Representative Transdermal Skin Patches Product
7.8.3 Transdermal Skin Patches Sales, Revenue, Price and Gross Margin of Purdue Pharma
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL SKIN PATCHES
8.1 Industry Chain of Transdermal Skin Patches
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL SKIN PATCHES
9.1 Cost Structure Analysis of Transdermal Skin Patches
9.2 Raw Materials Cost Analysis of Transdermal Skin Patches
9.3 Labor Cost Analysis of Transdermal Skin Patches
9.4 Manufacturing Expenses Analysis of Transdermal Skin Patches
CHAPTER 10 MARKETING STATUS ANALYSIS OF TRANSDERMAL SKIN PATCHES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
